Sjöquist PO - Search Results

1

Myocardial release of endothelin (ET) and enhanced ET(A) receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs.

Wang QD, Uriuda Y, Pernow J, Hemsén A, Sjöquist PO, Rydén L. Wang QD, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1995 Nov;26(5):770-6. doi: 10.1097/00005344-199511000-00014. J Cardiovasc Pharmacol. 1995. PMID: 8637192

2

Ischemic and nonischemic tissue concentrations of felodipine after coronary venous retroinfusion during myocardial ischemia and reperfusion: an experimental study in pigs.

Haga Y, Uriuda Y, Björkman JA, Hatori N, Johansson L, Nordlander R, Sjöquist PO, Rydén L. Haga Y, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1994 Aug;24(2):298-302. J Cardiovasc Pharmacol. 1994. PMID: 7526064

3

Beneficial effects of H290/51, a new lipid peroxidation inhibitor, on functional recovery after ischemia and reperfusion in isolated cold-arrested rat hearts.

Wang QD, Uriuda Y, Li XS, Nordlander R, Sjöquist PO, Rydén L. Wang QD, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1995 Jun;25(6):924-9. doi: 10.1097/00005344-199506000-00010. J Cardiovasc Pharmacol. 1995. PMID: 7564337

4

Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion.

Hatori N, Haga Y, Sjöquist PO, Nordlander M, Rydén L. Hatori N, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1993 Jul;22(1):160-6. doi: 10.1097/00005344-199307000-00024. J Cardiovasc Pharmacol. 1993. PMID: 7690089

5

Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosis.

Uriuda Y, Wang QD, Grip L, Rydén L, Sjöquist PO, Mattsson C. Uriuda Y, et al. Among authors: sjoquist po. Cardiovasc Res. 1996 Aug;32(2):320-7. doi: 10.1016/0008-6363(96)00114-9. Cardiovasc Res. 1996. PMID: 8796119

6

Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.

Uriuda Y, Wang QD, Li XS, Sjoquist PO, Nordlander R, Ryden L. Uriuda Y, et al. Among authors: sjoquist po. Cardiovasc Res. 1996 Jan;31(1):82-92. Cardiovasc Res. 1996. PMID: 8849592

7

Role of L-arginine in preventing myocardial and endothelial injury following ischaemia/reperfusion in the rat isolated heart.

Li XS, Uriuda Y, Wang QD, Norlander R, Sjöquist PO, Pernow J. Li XS, et al. Among authors: sjoquist po. Acta Physiol Scand. 1996 Jan;156(1):37-44. doi: 10.1046/j.1365-201X.1996.432152000.x. Acta Physiol Scand. 1996. PMID: 8866884

8

Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.

Uriuda Y, Wang QD, Hatori N, Nordlander R, Sjöquist PO, Mattsson C, Rydén L. Uriuda Y, et al. Among authors: sjoquist po. J Pharmacol Toxicol Methods. 1998 Mar;39(2):81-9. doi: 10.1016/s1056-8719(98)00006-9. J Pharmacol Toxicol Methods. 1998. PMID: 9694166

9

Angiotensin II type 1 receptor blockade with candesartan protects the porcine myocardium from reperfusion-induced injury.

Shimizu M, Wang QD, Sjöquist PO, Rydén L. Shimizu M, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1998 Aug;32(2):231-8. doi: 10.1097/00005344-199808000-00010. J Cardiovasc Pharmacol. 1998. PMID: 9700985

10

Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition.

Wang QD, Gonon A, Shimizu M, Sjöquist PO, Pernow J. Wang QD, et al. Among authors: sjoquist po. Acta Physiol Scand. 1998 Aug;163(4):325-30. doi: 10.1046/j.1365-201X.1998.t01-1-00364.x. Acta Physiol Scand. 1998. PMID: 9789575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters